<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00398203</url>
  </required_header>
  <id_info>
    <org_study_id>CLI-10111</org_study_id>
    <nct_id>NCT00398203</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Using NaviAid™ BGE Device (Balloon Guided Endoscopy) For Endoscopic Diagnosis and Treatment</brief_title>
  <official_title>Safety and Efficacy of Using NaviAid™ BGE Device (Balloon Guided Endoscopy) For Endoscopic Diagnosis and Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smart Medical Systems Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smart Medical Systems Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the efficacy of the NaviAid™ BGE Device, while used in conjunction with a standard&#xD;
      endoscope for the diagnosis and treatment of the small intestine.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Smart Medical Systems has developed the NaviAid™ Balloon Guided Endoscopy (BGE) Device, an&#xD;
      innovative medical device for the GI tract diagnosis and treatment. The Balloon Guided&#xD;
      Endoscopy (BGE) is a procedure intended for the examination of the small intestine, which&#xD;
      utilizes the NaviAid™ BGE Device in conjunction with a standard endoscope.&#xD;
&#xD;
      The objectives of this prospective controlled study are to evaluate the safety and efficacy&#xD;
      of using the NaviAid™ BGE device in the examination of the small intestine in conjunction&#xD;
      with a standard endoscope.&#xD;
&#xD;
      Efficacy will be assessed by comparing NaviAid™ BGE Device performances to a reference&#xD;
      Enteroscopy procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy will be assessed by comparing NaviAid™ BGE Device performances to a reference Enteroscopy procedure in terms of depth of small intestine advancement and visualization.</measure>
    <time_frame>Within 6 months of completion of the trial</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety of the NaviAid™ BGE Device will be assessed by reporting adverse events, and by comparing to a reference Enteroscopy procedure.</measure>
    <time_frame>Within 6 months of completion of the trial</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">60</enrollment>
  <condition>Intestinal Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NaviAid™ BGE Device</intervention_name>
    <description>NaviAid™ Balloon Guided Endoscopy Device</description>
    <other_name>NaviAid™ Balloon Guided Endoscopy Device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male/Female aged between 18-80 years (inclusive).&#xD;
&#xD;
          -  Subject is scheduled for endoscopic procedure after the case was reviewed by one of&#xD;
             the investigators.&#xD;
&#xD;
          -  Symptomatic subject defined as having at least one of the following signs or symptoms:&#xD;
&#xD;
               -  Abdominal pain&#xD;
&#xD;
               -  Cramps&#xD;
&#xD;
               -  Bloating&#xD;
&#xD;
               -  Diarrhea&#xD;
&#xD;
               -  Nausea&#xD;
&#xD;
               -  Vomiting&#xD;
&#xD;
               -  Unexplained Anemia&#xD;
&#xD;
               -  GI bleeding from an unknown source&#xD;
&#xD;
               -  Small bowel abnormality on any imaging study&#xD;
&#xD;
          -  Subject able to comprehend and give informed consent for participation in this study&#xD;
&#xD;
          -  Signed Informed Consent Form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Acute bowel obstruction&#xD;
&#xD;
          -  Concomitant Coumadin or warfarin use&#xD;
&#xD;
          -  Severe diverticulitis&#xD;
&#xD;
          -  Recent (within the last 3 months) coronary ischemia or CVA (stroke)&#xD;
&#xD;
          -  Any chronic unstable disease&#xD;
&#xD;
          -  Bleeding disorders&#xD;
&#xD;
          -  Needing emergency surgery&#xD;
&#xD;
          -  Any patient condition deemed too risky for SBE by the investigator&#xD;
&#xD;
          -  Known cognitive or psychiatric disorder&#xD;
&#xD;
          -  Physician objection&#xD;
&#xD;
          -  Concurrent participation in any other clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingvar Bjarnason, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kings College Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kings College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <study_first_submitted>November 8, 2006</study_first_submitted>
  <study_first_submitted_qc>November 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2006</study_first_posted>
  <last_update_submitted>June 11, 2012</last_update_submitted>
  <last_update_submitted_qc>June 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NaviAid™ BGE Device</keyword>
  <keyword>Small Intestine</keyword>
  <keyword>Intestinal Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

